top of page
Search
Glenn Hearson
Sep 8, 2021
Patient Story Videos Part 1 - Before the Trial
This is the 1st in a series of videos from four respiratory research volunteers who have taken part in asthma drug trials and talk about...
31
Glenn Hearson
Aug 20, 2021
The COMPAIR Study; A Comparison of Clinic-based Versus Home-based Spirometry
We will shortly be commencing an exciting new multi-site clinical research trial to assess spirometry tests performed in our research...
291
Glenn Hearson
Aug 20, 2021
PRISM: Molecular phenotyping of severe asthma patients to determine response to biologic therapies
We will shortly be commencing this important collaborative asthma research funded by a £2.3 million grant from the Medical Research...
195
Glenn Hearson
May 24, 2021
More positive results from #ANDHI study for Benralizumab in Severe Eosinophilic Asthma
The #ANDHI study, has recently had more results published in the European Journal of Allergy and Clinical Immunology " Benralizumab...
81
Glenn Hearson
Apr 1, 2021
Nottingham Asthma Centre Newsletter: Spring 2021
The Spring 2021 Asthma Newsletter is now out.
53
Glenn Hearson
Jan 2, 2021
Benralizumab study ANDHI shows early clinical benefits in #severe asthma patient-reported outcomes
Benralizumab study ANDHI shows early clinical benefits in #severe asthma patient-reported outcomes
160
Glenn Hearson
Nov 17, 2020
APEX Asthma Exacerbation Studies Newsletter
Our APEX research studies looking into asthma attacks (exacerbations) new newsletter is now available. The APEX Studies are...
68
Glenn Hearson
Nov 9, 2020
PONENTE study hits the mark in phase IIIb asthma trial
PONENTE Phase IIIb open-label Fasenra (benralizumab)
131
bottom of page